{
    "eid": "2-s2.0-85081674187",
    "title": "Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy",
    "cover-date": "2020-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Anti-tumor therapy",
        "Bacterial vector",
        "Breast cancer",
        "Cancer vaccine",
        "Delivery vehicle"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Lohanathan Bharathi Priya",
        "B. Mahalakshmi",
        "Shanmugam Subbiah",
        "Rouh Mei Hu",
        "Bharath Kumar Velmurugan",
        "Rathinasamy Baskaran"
    ],
    "citedby-count": 18,
    "ref-count": 111,
    "ref-list": [
        "Incidence and mortality of female breast cancer in the Asia-Pacific region",
        "A phase I-II study using rexin-G tumor-targeted retrovector encoding a dominant-negative cyclin G1 inhibitor for advanced pancreatic cancer",
        "Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells",
        "Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics",
        "Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: toward imaging-guided interventional gene therapy",
        "Gene\u2013environment interaction and risk of breast cancer",
        "Tumor endothelial heterogeneity in cancer progression",
        "Biodegradable polymers for gene delivery",
        "Influence of lifestyle factors on breast cancer risk",
        "Dose\u2013response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial",
        "Risk reduction strategies in breast cancer prevention",
        "Overview of breast cancer therapy",
        "Tumor cell lysates as immunogenic sources for cancer vaccine design",
        "Breast cancer immunotherapy: an update",
        "Development of the tumor-specific antigen-derived synthetic peptides as potential candidates for targeting breast and other possible human carcinomas",
        "Bacteria-cancer interactions: bacteria-based cancer therapy",
        "Chitosan in non-viral gene delivery: role of structure, characterization methods, and insights in cancer and rare diseases therapies",
        "Molecular subtypes and imaging phenotypes of breast cancer",
        "Therapeutic breast cancer vaccines",
        "Prophylactic anti-tumor immunity against a murine fibrosarcoma triggered by the Salmonella type III secretion system",
        "Clostridial spores to treat solid tumours - potential for a new therapeutic modality",
        "Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3-and-4-overexpressing tumors",
        "Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth",
        "Bacteria as vectors for gene therapy of cancer",
        "The emerging role of oncolytic virus therapy against cancer",
        "Tumor angiogenesis and anti-angiogenic gene therapy for cancer",
        "Bifidobacterium as a delivery system of functional genes for cancer therapy",
        "Immune tumor microenvironment in breast cancer and the participation of estrogens and its receptors into cancer physiopathology",
        "Targeted cancer therapy using engineered Salmonella typhimurium",
        "Cancer DNA vaccines: current preclinical and clinical developments and future perspectives",
        "New strategies for therapeutic cancer vaccines",
        "Salmonella-mediated cancer therapy: roles and potential",
        "Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities",
        "Global Cancer in Women: Burden and Trends",
        "Viral vector-based therapeutic cancer vaccines",
        "Novel tumour antigens and the development of optimal vaccine design",
        "Developments in high-yield system expressed vaccines and immunotherapy",
        "Viral gene therapy for breast cancer: progress and challenges",
        "Design and pre-clinical evaluation of a universal HIV-1 vaccine",
        "Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys",
        "Oncolytic viral therapy and the immune system: a double-edged sword against cancer",
        "Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies",
        "Oncolytic viruses: how \u201clytic\u201d must they be for therapeutic efficacy?",
        "Vaccine delivery methods using viral vectors",
        "An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell",
        "Conditionally replicating adenoviruses for cancer treatment",
        "Inhibition of Breast Cancer Cells by Targeting E2F-1 Gene and Expressing IL15 Oncolytic Adenovirus, Bioscience Reports, 39",
        "Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo",
        "Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer",
        "Enhanced clearance of HIV-1\u2013infected cells by broadly neutralizing antibodies against HIV-1 in vivo",
        "Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors",
        "Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1",
        "Current status of gene therapy for breast cancer: progress and challenges",
        "A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein",
        "Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer",
        "Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma",
        "Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ",
        "Biology and pathogenicity of autonomous parvoviruses",
        "Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1",
        "Immune conversion of tumor microenvironment by oncolytic viruses: the protoparvovirus H-1PV case study",
        "Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures",
        "TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma",
        "Talimogene laherparepvec: first in class oncolytic virotherapy",
        "Novel immunotherapeutic approaches in targeting dendritic cells with virus vectors",
        "Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses",
        "In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses",
        "Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12",
        "CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment, Frontiers in Immunology, 10",
        "CAR-T cells and oncolytic viruses: joining forces to overcome the solid tumor challenge",
        "CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation",
        "The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer End Results in 449 Cases: A Study and Abstracts of Reports in the World Medical Literature (1775\u20131980) and Personal Communications, Cancer Research Institute",
        "The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas",
        "Bacteria: prospective savior in battle against cancer",
        "Combination bacteriolytic therapy for the treatment of experimental tumors",
        "Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium",
        "Attenuated bacteria as immunotherapeutic tools for cancer treatment",
        "White paper on microbial anti-cancer therapy and prevention",
        "Increasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori",
        "RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated salmonella-mediated cancer therapy",
        "High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action",
        "Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers",
        "Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models",
        "Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice",
        "Apoptosis or growth arrest: modulation of tumor suppressor p53\u2019s specificity by bacterial redox protein azurin",
        "Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein",
        "Explicit hypoxia targeting with tumor suppression by creating an \u201cobligate\u201d anaerobic Salmonella Typhimurium strain",
        "Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth",
        "Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer",
        "Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine",
        "Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium",
        "EpCAM-specific vaccine response by modified antigen and chimeric costimulatory molecule in cynomolgus monkeys",
        "Development of Globo-H cancer vaccine",
        "Breast cancer vaccine shows promise",
        "Mammaglobin-a cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells",
        "Anti-HER2 vaccines: new prospects for breast cancer therapy",
        "Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine",
        "Listeria monocytogenes as a vector for anti-cancer therapies",
        "Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105",
        "Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells",
        "Chemovirotherapeutic treatment using camptothecin enhances oncolytic measles virus-mediated killing of breast cancer cells",
        "Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity",
        "Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III\u2013IV melanoma",
        "Clinical trials with oncolytic measles virus: current status and future prospects",
        "First in Human (FIH) Dose Escalation Studies of Intravenous Administration of VSV-IFN beta-NIS (Voyager-V1 (TM)) in Stage IV or Recurrent Endometrial Cancer",
        "A phase II study of pelareorep (REOLYSIN\u00ae) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma",
        "Phase I trial of an ICAM-1-targeted immunotherapeutic-coxsackievirus A21 (CVA21) as an oncolytic agent against non muscle-invasive bladder cancer",
        "Live bacterial vaccine vectors: an overview",
        "IL-18-producing Salmonella inhibit tumor growth",
        "L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors",
        "Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy",
        "An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model"
    ],
    "affiliation": [
        {
            "affiliation-city": "Da Nang",
            "@id": "60111656",
            "affilname": "Duy Tan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111656",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Ho Chi Minh City",
            "@id": "60078563",
            "affilname": "Ton-Duc-Thang University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60078563",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60072429",
            "affilname": "Asia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072429",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60031941",
            "affilname": "China Medical University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031941",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Coimbatore",
            "@id": "60013041",
            "affilname": "Bharathiar University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013041",
            "affiliation-country": "India"
        }
    ],
    "funding": []
}